Judith A. James

发表

Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons

P. Gaffney, R. Jonsson, B. Segal, 2017, PLoS genetics.

Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression.

P. Gaffney, M. Weirauch, M. Petri, 2015, American journal of human genetics.

Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study

P. Gaffney, M. Petri, C. Langefeld, 2015, Genes and Immunity.

Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus

P. Gregersen, P. Gaffney, M. Petri, 2011, Nature Genetics.

Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility

R. Cantor, P. Gaffney, M. Petri, 2011, PLoS genetics.

Variable Association of Reactive Intermediate Genes with Systemic Lupus Erythematosus in Populations with Different African Ancestry

P. Gaffney, M. Petri, J. Reveille, 2013, The Journal of Rheumatology.

A plausibly causal functional lupus-associated risk variant in the STAT1–STAT4 locus

Daniel E. Miller, P. Gaffney, M. Weirauch, 2018, Human molecular genetics.

ABIN1 dysfunction as a genetic basis for lupus nephritis.

R. K. Oliver, P. Gaffney, P. Cohen, 2013, Journal of the American Society of Nephrology : JASN.

Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study.

P. Gregersen, P. Gaffney, M. Petri, 2011, American journal of human genetics.

Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus

P. Lipsky, D. Karp, E. Wakeland, 2007, Annals of the rheumatic diseases.

Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis

P. Gaffney, M. Petri, J. Reveille, 2011, Genes and Immunity.

X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome

P. Gaffney, R. Jonsson, K. Siminovitch, 2015, Arthritis & rheumatology.

potential roles in

H. Maecker, J. Guthridge, J. Merrill, 2023 .

Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface1

John D Lambris, J. Lambris, S. Perkins, 2001, The Journal of Immunology.

Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.

J. Harley, G. Gilkeson, J. Robertson, 2012, Arthritis and rheumatism.

Multiple Autoantibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a Large, Ethnically Diverse SLE Patient Cohort

M. Weisman, J. Harley, G. Gilkeson, 2012, Autoimmune diseases.

A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome

T. Radstake, J. Guthridge, A. Sawalha, 2023, medRxiv.

Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial

J. Guthridge, A. Askanase, F. Koumpouras, 2023 .

Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans

S. Frank, M. Petri, J. Reveille, 2008, Genes and Immunity.